SCHEMBL1701083

SCHEMBL1701083

Oc1c(C(Nc2ccc(Cl)cn2)c2ccccn2)ccc2cccnc12

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.77
MAPT P10636 2/20 0.77
KDM4E B2RXH2 1/20 0.77
USP2 O75604 1/20 0.77
LMNA P02545 1/20 0.77
ALOX15 P16050 1/20 0.77
NFKB1 P19838 1/20 0.77
MAPK1 P28482 1/20 0.77
HTT P42858 1/20 0.77
PPP1CA P62136 1/20 0.77
NFKB2 Q00653 1/20 0.77
RELA Q04206 1/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
L3MBTL1 Q9Y468 1/20 0.77
MDM2 Q00987 7/20 0.70
P4HB P07237 4/20 0.68
GRK6 P43250 2/20 0.63
JMJD7 P0C870 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16810181 0.87 TP53 (1.00) TP53MAPTKDM4EUSP2LMNA
SCHEMBL9965518 0.87 MDM2 (0.80) TP53MAPTUSP2LMNAMDM2
SCHEMBL1700910 0.87 TP53 (0.77) TP53MAPTKDM4EUSP2LMNA
SCHEMBL9965528 0.87 MDM2 (0.83) TP53MAPTKDM4ESMN1; SMN2TDP1
SCHEMBL9965705 0.85 MDM2 (0.79) TP53MAPTKDM4ESMN1; SMN2TDP1
SCHEMBL9965647 0.85 P4HB (0.78) TP53MAPTKDM4EUSP2LMNA
SCHEMBL9965679 0.85 MDM2 (0.82) TP53MAPTMDM2P4HB
SCHEMBL9965590 0.84 MDM2 (0.82) TP53MAPTKDM4EMDM2P4HB
SCHEMBL9965519 0.83 MDM2 (0.71) TP53MAPTUSP2LMNAMDM2
SCHEMBL9965665 0.83 MDM2 (0.80) TP53MAPTKDM4ESMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131096-A1 8-HYDROXY-QUINOLINE DERIVATIVES UBICHEM KUTATO KORLATOLT FELELOSSEGU TARSASAG (HU) 2013-05-23 US claimed
EP-2566849-A1 8-HYDROXY-QUINOLINE DERIVATIVES "Avidin" Kutató, Fejleszt És Kereskedelmi Korlatolt Felelossegu Tarsasag (HU) 2013-03-13 EP claimed
WO-2011148208-A1 8-HYDROXY-QUINOLINE DERIVATIVES "AVIDIN" KUTATÓ, FEJLESZTŐ ÉS KERESKEDELMI KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG (HU) 2011-12-01 WO claimed
EP-2566849-B1 8-HYDROXY-QUINOLINE DERIVATIVES AVIDIN KUTATO FEJLESZTOE ES KERESKEDELMI KORLATOLT FELELOESSEGUE TARSASAG (HU) 2019-09-18 EP disclosed
EP-2566849-B1 8-HYDROXY-QUINOLINE DERIVATIVES AVIDIN KUTATO FEJLESZTOE ES KERESKEDELMI KORLATOLT FELELOESSEGUE TARSASAG (HU) 2019-09-18 EP disclosed
US-8871937-B2 8-hydroxy-quinoline derivatives “AVIDIN” Kutato, Fejleszto es Kereskedelmi Korlatolt Felelossegu Tarsasag (HU) 2014-10-28 US disclosed
US-8871937-B2 8-hydroxy-quinoline derivatives “AVIDIN” Kutato, Fejleszto es Kereskedelmi Korlatolt Felelossegu Tarsasag (HU) 2014-10-28 US disclosed
US-8871937-B2 8-hydroxy-quinoline derivatives “AVIDIN” Kutato, Fejleszto es Kereskedelmi Korlatolt Felelossegu Tarsasag (HU) 2014-10-28 US disclosed
US-20130131096-A1 8-HYDROXY-QUINOLINE DERIVATIVES UBICHEM KUTATO KORLATOLT FELELOSSEGU TARSASAG (HU) 2013-05-23 US disclosed
US-20130131096-A1 8-HYDROXY-QUINOLINE DERIVATIVES UBICHEM KUTATO KORLATOLT FELELOSSEGU TARSASAG (HU) 2013-05-23 US disclosed
US-20130131096-A1 8-HYDROXY-QUINOLINE DERIVATIVES UBICHEM KUTATO KORLATOLT FELELOSSEGU TARSASAG (HU) 2013-05-23 US disclosed
WO-2011148208-A1 8-HYDROXY-QUINOLINE DERIVATIVES "AVIDIN" KUTATÓ, FEJLESZTŐ ÉS KERESKEDELMI KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG (HU) 2011-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131096-A1 8-HYDROXY-QUINOLINE DERIVATIVES CYP2C8, NQO1, KEAP1 TP53 4173/4885MAPT 2319/4885KDM4E 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.